J M Mwenda
Overview
Explore the profile of J M Mwenda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurry C, Mwenda J, Nardone A, Cohuet S, Worwui A, Valenciano M, et al.
Vaccine
. 2025 Jan;
:126616.
PMID: 39743459
Population-level vaccination with newly developed vaccines to respond to the COVID-19 pandemic created a need to monitor vaccine effectiveness (VE) in the context of emerging SARS-CoV-2 variants and changing epidemiology....
2.
Kraay A, Steele M, Baker J, Hall E, Deshpande A, Saidzosa B, et al.
Vaccine
. 2022 Oct;
40(46):6631-6639.
PMID: 36210251
Rotavirus vaccination has been shown to reduce rotavirus burden in many countries, but the long-term magnitude of vaccine impacts is unclear, particularly in low-income countries. We use a transmission model...
3.
Mokomane M, Esona M, Bowen M, Tate J, Steenhoff A, Lechiile K, et al.
Vaccine
. 2019 Sep;
37(43):6324-6328.
PMID: 31530468
Background: Globally, rotavirus is the leading cause of acute gastroenteritis (AGE) in children aged <5 years. Botswana introduced the monovalent rotavirus vaccine (Rotarix) in July 2012. To study the impact...
4.
Tagbo B, Mwenda J, Eke C, Edelu B, Chukwubuike C, Armah G, et al.
Vaccine
. 2018 May;
36(51):7759-7764.
PMID: 29802002
Background: The high burden of rotavirus acute gastroenteritis (AGE) is well documented among children under 5 years of age, with the majority of mortality occurring in developing countries. Nigeria ranked...
5.
Mpabalwani E, Simwaka J, Mwenda J, Matapo B, Parashar U, Tate J
Vaccine
. 2018 May;
36(47):7165-7169.
PMID: 29793891
Background: Monovalent rotavirus vaccine (RV1) was introduced in Lusaka in February 2012 and rolled out countrywide in November 2013 in the routine Expanded Programme on Immunisation and administered at 6...
6.
Seheri L, Magagula N, Peenze I, Rakau K, Ndadza A, Mwenda J, et al.
Vaccine
. 2017 Dec;
36(47):7222-7230.
PMID: 29203181
Background: The African Rotavirus Surveillance Network has been detecting and documenting rotavirus genotypes in the African sub-continent since 1998 in anticipation of the rollout of rotavirus vaccination in routine Expanded...
7.
Rahajamanana V, Raboba J, Rakotozanany A, Razafindraibe N, Andriatahirintsoa E, Razafindrakoto A, et al.
Vaccine
. 2017 Sep;
36(47):7198-7204.
PMID: 28958809
Background: Rotavirus vaccine was introduced into the Extended Program on Immunization in Madagascar in May 2014. We analyzed trends in prevalence of all cause diarrhea and rotavirus hospitalization in children...
8.
Kiulia N, Mans J, Mwenda J, Taylor M
Food Environ Virol
. 2014 Jul;
6(4):221-31.
PMID: 25059212
In this study, the prevalence and genotypes of noroviruses (NoVs) in selected water sources from rural, urban and refugee settings in Kenya were investigated. Ten litres each of river, household...
9.
Seheri L, Mwenda J, Page N
Vaccine
. 2014 May;
32(48):6336-41.
PMID: 24837779
The 7th African Rotavirus Symposium was held in Cape Town, South Africa, on the 8th November 2012 as a Satellite Symposium at the First International African Vaccinology Conference. Over 150...
10.
Dancet E, Brannstrom M, Brasky K, Chai D, Chan A, Conn P, et al.
Biol Reprod
. 2012 Dec;
88(2):33.
PMID: 23255340
No abstract available.